Watch the latest episode of focusIR Fireside Chats: Why Edinburgh Investment Trust Is Backing Turnaround Stocks for 2026 Growth. View here

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksPollen Street Regulatory News (POLN)

Share Price Information for Pollen Street (POLN)

Share Price is delayed by 15 minutes
Get Live Data
830.00    5.00 (0.61%)
Bid:
871.00
Ask:
790.00
Spread: -81.00 (-9.30%)
Market Cap: £493.45m
POLN Live PriceLast checked at - London Stock Exchange

Intraday Pollen Street Share Chart

Q1 2025 Trading Update

15 May 2025 07:00

RNS Number : 7341I
Pollen Street Group Limited
15 May 2025
 

15 May 2025

Pollen Street Group Limited: Q1 2025 Trading Update

Pollen Street Group Limited ("Pollen Street", together with its subsidiaries, the "Group") today issues a trading update for the quarter ended 31 March 2025.Strong fundraising momentum continued to drive AuM growth during the period.

Asset Manager

· Total AuM increased to £5.8 billion as of 31 March 2025. This comprised £3.7 billion in Private Equity and £2.1 billion in Private Credit.

· Fee-paying AuM increased to £4.3 billion as of 31 March 2025, up from £4.0 billion in December 2024. This was made up of £2.8 billion in Private Equity and £1.5 billion in Private Credit.

· Private Equity V fundraising continues to progress well, having already surpassed the target of €1 billion. Management expects the final close in mid-2025 to be 20% - 40% above this target.

· Private Credit IV has good visibility on achieving its £1 billion fundraising target during 2025, with the final close now targeted materially above this level.

Investment Company

· The Investment Company has generated an annualised net investment return of 8.6% in the year-to-date. This reflects the expected seasonal profile of returns on the equity portfolio with forecast full year returns remaining in line with expectations. As of 31 March 2025, Investment Assets stood at £518million.

· The Investment Company has committed c.£196 million to Pollen Street funds, of which 69% was drawn as of 31 March 2025.

Pollen Street continues to deliver on Management's growth expectations and maintains a robust outlook for the remainder of FY25 and beyond despite recent increased macroeconomic volatility.

About Pollen Street

Pollen Street is an alternative asset manager dedicated to investing within the financial and business services sectors across both Private Equity and Private Credit strategies. The business was founded in 2013 and has consistently delivered top tier returns alongside growing AuM.

 

Pollen Street benefits from a complementary set of asset management activities focused on managing third-party AuM (the "Asset Manager") together with on-balance sheet investments (the "Investment Company").

 

The Asset Manager raises capital from high quality investors and deploys it into its Private Equity and Private Credit strategies. The strong recurring revenues from this business enable delivery of scalable growth.

 

The Investment Company invests in the strategies of the group delivering attractive risk adjusted returns and accelerating growth in third-party AuM of the Asset Manager through investing in Pollen Street funds, taking advantage of attractive investment opportunities and aligning interest with our investors to grow AuM. Today the portfolio is largely invested in credit assets with the allocation to Private Equity expected to increase to 30 per cent in the long term. The portfolio consists of both direct investments and investments in funds managed by Pollen Street.

 

POLN is listed on the London Stock Exchange (ticker symbol: POLN) and is a member of the FTSE 250 index. Further details are available at www.pollenstreetgroup.com.

 

For further information about this announcement please contact:

 

Pollen Street - Corporate Development Director

Shweta Chugh

+44 (0)20 3965 5081

 

Barclays Bank plc - Joint Broker

Neal West / Stuart Muress

+44 (0)20 7623 2323

 

Investec Bank plc - Joint Broker

Ben Griffiths / Kamalini Hull

+44 (0)20 7597 4000

 

FGS Global

Chris Sibbald / Anna Tabor

PollenStreetCapital-LON@fgsglobal.com

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
TSTUSRARVAUVAUR
Date   Source Headline
29th Jun 20263:36 pmRNSDirector/PDMR Shareholding
17th Jun 20267:00 amRNSTransaction in Own Shares
1st Jun 20263:01 pmRNSTotal Voting Rights
27th May 20264:46 pmRNSDirector/PDMR Shareholding
27th May 20267:00 amRNSTransaction in Own Shares
20th May 20267:00 amRNSTransaction in Own Shares
11th May 20265:39 pmRNSDirector/PDMR Shareholding
7th May 20267:00 amRNSQ1 2026 Trading Update
6th May 20264:40 pmRNSDirector/PDMR Shareholding
1st May 20269:49 amRNSTotal Voting Rights
1st May 20268:12 amRNSResult of AGM
28th Apr 20264:31 pmRNSDirector/PDMR Shareholding
16th Apr 20265:31 pmRNSInvestor Presentation via Investor Meet Company
14th Apr 20267:00 amRNSHolding(s) in Company
10th Apr 20267:00 amRNSTransaction in Own Shares
27th Mar 202610:36 amRNSDirector/PDMR Shareholding
26th Mar 20264:37 pmRNSDirector/PDMR Shareholding
26th Mar 20267:30 amRNSDividend Declaration
26th Mar 20267:00 amRNSFull Year 2025 Trading Update
2nd Mar 202611:26 amRNSTotal Voting Rights
2nd Mar 20267:00 amRNSTransaction in Own Shares
27th Feb 20261:57 pmRNSDirector/PDMR Shareholding
27th Feb 20267:00 amRNSTransaction in Own Shares
26th Feb 20267:00 amRNSTransaction in Own Shares
25th Feb 20267:00 amRNSTransaction in Own Shares
24th Feb 20267:00 amRNSTransaction in Own Shares
18th Feb 20267:00 amRNSTransaction in Own Shares
17th Feb 20267:00 amRNSTransaction in Own Shares
13th Feb 20267:00 amRNSTransaction in Own Shares
9th Feb 20267:00 amRNSTransaction in Own Shares
2nd Feb 20264:32 pmRNSDirector/PDMR Shareholding
2nd Feb 20263:12 pmRNSTotal Voting Rights
30th Jan 202610:59 amRNSDirectorate changes
28th Jan 202611:37 amRNSDirector/PDMR Shareholding
27th Jan 20267:00 amRNSTransaction in Own Shares
26th Jan 20267:00 amRNSDirectorate change
23rd Jan 20267:00 amRNSTransaction in Own Shares
20th Jan 20267:00 amRNSTransaction in Own Shares
15th Jan 20267:00 amRNSTransaction in Own Shares
2nd Jan 20267:00 amRNSTotal Voting Rights
30th Dec 20254:27 pmRNSDirector/PDMR Shareholding
23rd Dec 20257:00 amRNSTransaction in Own Shares
11th Dec 20259:50 amRNSUpdate Statement on 2025 AGM Voting Results
1st Dec 202511:15 amRNSTotal Voting Rights
28th Nov 20256:23 pmRNSDirector/PDMR Shareholding
18th Nov 20257:00 amRNSQ3 2025 Trading Update
17th Nov 20257:00 amRNSTransaction in Own Shares
5th Nov 20257:00 amRNSAnnouncement of New Share Buyback Programme
16th Oct 20256:16 pmRNSHolding(s) in Company
3rd Oct 202511:32 amRNSDirector/PDMR Shareholding

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.